PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GILD vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GILD and LLY is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

GILD vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
33.32%
-12.87%
GILD
LLY

Key characteristics

Sharpe Ratio

GILD:

0.91

LLY:

1.18

Sortino Ratio

GILD:

1.38

LLY:

1.78

Omega Ratio

GILD:

1.20

LLY:

1.23

Calmar Ratio

GILD:

0.76

LLY:

1.47

Martin Ratio

GILD:

1.55

LLY:

4.28

Ulcer Index

GILD:

14.55%

LLY:

8.29%

Daily Std Dev

GILD:

24.71%

LLY:

30.04%

Max Drawdown

GILD:

-70.82%

LLY:

-68.27%

Current Drawdown

GILD:

-4.65%

LLY:

-19.89%

Fundamentals

Market Cap

GILD:

$115.65B

LLY:

$700.23B

EPS

GILD:

$0.09

LLY:

$9.27

PE Ratio

GILD:

1.03K

LLY:

83.99

PEG Ratio

GILD:

0.53

LLY:

0.74

Total Revenue (TTM)

GILD:

$28.30B

LLY:

$40.86B

Gross Profit (TTM)

GILD:

$22.07B

LLY:

$33.33B

EBITDA (TTM)

GILD:

$3.92B

LLY:

$12.51B

Returns By Period

In the year-to-date period, GILD achieves a 18.94% return, which is significantly lower than LLY's 32.57% return. Over the past 10 years, GILD has underperformed LLY with an annualized return of 3.79%, while LLY has yielded a comparatively higher 29.62% annualized return.


GILD

YTD

18.94%

1M

5.32%

6M

33.32%

1Y

22.07%

5Y*

11.19%

10Y*

3.79%

LLY

YTD

32.57%

1M

1.90%

6M

-12.87%

1Y

35.10%

5Y*

44.05%

10Y*

29.62%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GILD vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GILD, currently valued at 0.91, compared to the broader market-4.00-2.000.002.000.911.18
The chart of Sortino ratio for GILD, currently valued at 1.38, compared to the broader market-4.00-2.000.002.004.001.381.78
The chart of Omega ratio for GILD, currently valued at 1.20, compared to the broader market0.501.001.502.001.201.23
The chart of Calmar ratio for GILD, currently valued at 0.76, compared to the broader market0.002.004.006.000.761.47
The chart of Martin ratio for GILD, currently valued at 1.55, compared to the broader market-5.000.005.0010.0015.0020.0025.001.554.28
GILD
LLY

The current GILD Sharpe Ratio is 0.91, which is comparable to the LLY Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of GILD and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JulyAugustSeptemberOctoberNovemberDecember
0.91
1.18
GILD
LLY

Dividends

GILD vs. LLY - Dividend Comparison

GILD's dividend yield for the trailing twelve months is around 3.33%, more than LLY's 0.68% yield.


TTM20232022202120202019201820172016201520142013
GILD
Gilead Sciences, Inc.
3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%0.00%0.00%
LLY
Eli Lilly and Company
0.68%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%3.84%

Drawdowns

GILD vs. LLY - Drawdown Comparison

The maximum GILD drawdown since its inception was -70.82%, roughly equal to the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for GILD and LLY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-4.65%
-19.89%
GILD
LLY

Volatility

GILD vs. LLY - Volatility Comparison

The current volatility for Gilead Sciences, Inc. (GILD) is 5.61%, while Eli Lilly and Company (LLY) has a volatility of 7.16%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%JulyAugustSeptemberOctoberNovemberDecember
5.61%
7.16%
GILD
LLY

Financials

GILD vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab